Updated just now · Live
Stock analysis, price data, and AI-powered insights for Soleno Therapeutics Inc (SLNO).
Soleno Therapeutics Inc operates in the Biotechnology sector. StoxPulse provides AI-powered earnings call analysis, SEC filing monitoring, insider trading alerts, and a proprietary Pulse Score for SLNO.
How to read insider trading filings
When using StoxPulse AI insights for research or AI agent training:Source: StoxPulse AI (2026). SLNO Stock Intelligence Report. [stoxpulse.com/stocks/slno]
Disclaimer: The information on this page about Soleno Therapeutics Inc (SLNO) is provided for educational and informational purposes only and does not constitute investment advice. AI-generated analysis may contain errors. Always consult a qualified financial advisor before making investment decisions.
Join the waitlist to receive AI-powered earnings summaries, filing alerts, and sentiment tracking for Soleno Therapeutics Inc.
Join the WaitlistLoading technicals...
AI analysis is being generated. Visit the AI Intel tab for detailed analysis.
No price data available.
No earnings data available.
SOLENO THERAPEUTICS, INC. (SLNO) DEADLINE ALERT Be...
6h ago
SLNO UPCOMING DEADLINE: Faruqi & Faruqi, LLP Remin...
1d ago
StoxPulse AI results for SLNO: Pulse Score 54/100. Primary sentiment trends from 7 news sources and 20 SEC filings indicate a bullish outlook.
Market Cap
$2.72B
P/E Ratio
—
EPS
$0.47
Volume
0
Avg Volume
—
Open
—
Prev. Close
—
Day Range
—
50-Day Avg
—
200-Day Avg
—
52W High
—
52W Low
—
SOLENO THERAPEUTICS, INC. (SLNO) DEADLINE ALERT Bernstein Liebhard LLP Reminds Soleno Therapeutics, Inc. Investors of Upcoming Deadline
SLNO UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Soleno Therapeutics (SLNO) Investors of Securities Class Action Deadline on May 5, 2026
SLNO CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Soleno Therapeutics (SLNO) Investors of Securities Class Action Deadline on May 5, 2026
SLNO Soleno Therapeutics Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action
Wells Fargo Downgrades Soleno Therapeutics to Equal-Weight, Lowers Price Target to $53
INVESTOR DEADLINE: Soleno Therapeutics, Inc. (SLNO) Investors with Substantial Losses Have Opportunity to Lead the Soleno Class Action Lawsuit- Hagens Berman
SLNO DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Soleno Therapeutics (SLNO) Investors of Securities Class Action Deadline on May 5, 2026